Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-01-09
1998-07-07
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514322, 514393, 514394, 514395, 544139, 546199, 5483021, A61K 31535, A61K 31445, A61K 31415, C09D41300, C09D42100, C09D23502
Patent
active
057769311
ABSTRACT:
which are useful in treating a condition associated with an excess of neuropeptide Y. This invention also provides methods employing these formulations with comprise as an active ingredient one or more of these compounds.
REFERENCES:
patent: 4623379 (1986-11-01), Baum et al.
Nunes Anne Marie
Zarrinmayeh Hamideh
Boone David E.
Eli Lilly and Company
Gaylo Paul J.
Jarvis William R. A.
LandOfFree
Naphthimidazolyl neuropeptide Y receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthimidazolyl neuropeptide Y receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthimidazolyl neuropeptide Y receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206115